SYNTHOS RESEARCH

Moody's MCO

Financial Services · Financial - Data & Stock Exchanges · Synthos Deep Dive · 2026-08-04

$514.95
Hold
—
—

The Overview

When a company or a government borrows money by issuing a bond, investors want an independent opinion on how likely it is to be repaid. Two firms provide most of those opinions worldwide: Moody's and S&P Global. Moody's rates roughly 40% of the world's debt.

This is an unusually good business, and the reason is simple. A rating from Moody's typically lowers a borrower's interest cost by more than the rating fee. So issuers pay, and they keep paying, and a new entrant cannot easily persuade investors to accept an unfamiliar opinion. Our knowledge base contains five separate expert claims about this company and every one is positive. One calls it "an unassailable protocol-network-effect moat" and says it is "ownable for 30+ years."

Moody's also owns a second business selling credit data, research and risk software. It is about as large as the ratings business by the vendor's labelling and it is growing much more slowly — 4% in the most recent quarter.

The recent quarter looked spectacular: earnings per share of $5.02 against $3.20 a year earlier, up 57%. But reading the actual filing shows the company sold a business during the quarter — MA Regulatory Solutions — and booked a gain on it. Strip the below-the-line items and the operating profit grew 24%. Still very good; not 57%.

The shares cost $483.67, which is about 25.6 times what analysts expect Moody's to earn in 2027. Those same analysts expect earnings to grow about 12% a year. Paying 25.6 times for 12% growth is a full price for a great business.

Our estimate of fair value is $491 — essentially where the shares already trade. In a bad case they fall to about $360; in a good case they reach about $619. That is roughly one dollar of possible gain per dollar of possible loss. So: Hold.

There is one thing worth knowing about the risk. This business does not lose customers; it loses volume. In 2022, when interest rates rose and companies stopped issuing bonds, Moody's revenue fell 12% and its profit fell 38% — in a single year, with the moat entirely intact. That is the shape of the downside.

Two data notes. The vendor's file reports Moody's United States revenue as $472 million. The correct figure is about $4,171 million — nearly nine times larger — because the file has mislabelled a residual line. And the file's own reports for this company contain no financial tables at all, so we could not check its capital-spending figure against the original documents; the number it implies has fallen 75% in a year, which we flag without being able to resolve.

Putting a number on it: our fair-value estimate is $491 against a current price of $514.95 — a premium price for a business we still like.

Our summary metrics

Downside Risk (lower = safer)4/10Moderate

"Rated 4 — the LOWEST risk score in this batch, and it is earned by the business model rather than the balance sheet. Moody's Investors Service is one of two firms that rate the substantial majority of the world's debt, and the knowledge base's own description — 'a natural duopoly rating 90% of world debt', 'an unassailable protocol-network-effect moat' — is not marketing but a reasonable statement of the industry structure. The financial evidence: a 45.1% trailing operating margin, a 49.0% EBITDA margin, a 34.3% net margin, a 23.9% return on invested capital, `netDebtToEBITDATTM` of 1.51x, and $2,448 million of cash and short-term investments against $7,351 million of total debt with no short-term borrowings at all at 2025-12-31. Trailing free cash flow is roughly $3.2 billion on $7.7 billion of revenue. Against that, four real exposures. Ratings revenue is levered to global debt ISSUANCE, which is cyclical and rate-sensitive — Moody's revenue fell from $6,218 million in FY2021 to $5,468 million in FY2022 when issuance froze, a 12.1% decline, and earnings fell 38%. Regulatory and litigation exposure is permanent and has been material before. Shareholders' equity of $4,054 million against $8,234 million of goodwill and intangibles and $14,978 million of treasury stock makes price-to-book of 28.1x and return on equity of 79.7% artefacts rather than measurements. And the filing extraction is prose-only, so no financial-statement line in this dive is filing-verified."

Growth Quality6/10High

"Rated 6 — steady, price-led, and slower than the multiple implies. Revenue: $5,371M (FY2020), $6,218M (FY2021), $5,468M (FY2022), $5,916M (FY2023), $7,088M (FY2024), $7,718M (FY2025). The FY2022 decline of 12.1% is the important data point in that series: when debt issuance stops, this business shrinks. The recent trajectory is strong — FY2024 +19.8%, FY2025 +8.9% — and the June 2026 quarter delivered $2,185M, up 15.1%, with the 10-Q noting operating margin expansion 'reflects the 15% increase in revenue, partially offset by growth of 5% in operating and SG&A expenses'. That five-versus-fifteen gap is the operating leverage this franchise has when issuance is open. The segment detail is more mixed: the 10-Q reports Moody's Analytics revenue up only 4% globally (US +7%, international +2%) with organic constant-currency growth of 8% — so the recurring, subscription half of the company is growing at mid-single digits while the cyclical ratings half carries the quarter. Consensus wants EPS of $16.92 in FY2026 (16 analysts), $18.90 in FY2027 (16) and $21.11 in FY2028 (8) — 14.9%, then 11.7%, then 11.7% — on revenue growth of 7.4%, 7.4% and 7.6%. What holds this at 6: roughly four points of the EPS growth is buyback and margin, the analytics business is growing 4%, and the whole thing rests on debt issuance staying open."

Exponential Potential4/10Moderate

"Rated 4 — an exceptional moat attached to a linear revenue base, with one genuine option. What Moody's owns is a standard: the knowledge base's business_breakdowns claim describes it precisely — 'Like Moody's/S&P in ratings, FICO is the accepted securitization standard — using an alternative costs ~0-50bps more interest, so the standard is entrenched.' A rating that lowers a borrower's cost of capital by tens of basis points is worth far more than it costs, which is why pricing power of 3-4% a year is durable and why the same speaker puts terminal-value certainty high enough to call it 'ownable for 30+ years'. That is a superb business and it is not an exponential one: ratings revenue scales with the number and size of debt issues, which grows with nominal GDP. The option is Moody's Analytics, at $4,840 million of FY2025 revenue on the vendor's labelling — a data, research and risk-software business the 10-K describes as powering 'AI-enabled cloud-based workflow tools'. If the proprietary credit dataset built over a century becomes a machine-learning asset rather than a publishing asset, the economics change. The evidence so far is unimpressive: MA revenue grew 4% in the June quarter, 8% organic constant currency, and the company divested MA Regulatory Solutions in the same quarter — a narrowing, not a scaling. A 4, not higher, because the moat is real and the growth curve is not accelerating."

Fair value$491 $360–$619
What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

The Road Ahead

What we expect to matter in each window, and the evidence that would prove us wrong.

Short term 0-6 months

Neutral
Driver
"A quality name in a mild, orderly de-rating. Moody's closed 2026-08-04 at $483.67, up 0.06% on 502,000 shares — the lightest volume in this batch — which is 10.37% below the 52-week high of $539.61 and 17.33% above the low of $412.23. The shares sit 3.0% above a 50-day moving average of $469.48 and 2.5% above a 200-day of $471.80, with RSI at 38.4 — soft but not oversold — and MACD positive at +2.77. Three-month return is +7.59%, exactly in line with SPY's +7.59%; six-month is −6.46% against +11.09%; and twelve-month is −3.51% against SPY's +24.26%, a twenty-eight-point deficit. So this is a stock that has done nothing for a year while the index rose a quarter. The June quarter was strong on the operating line — revenue +15.1%, operating income +24.1% — and the headline diluted EPS of $5.02 against $3.20 is inflated by a divestiture gain the 10-Q names. The stance is neutral because at 25.6x FY2027 consensus the multiple is full for 11.7% growth, and because the base fair value sits 1.6% above spot."
What we’re watching
"The third-quarter release, expected late October. Two lines matter more than the headline: Moody's Investors Service revenue, which is the cyclical half and carried the June quarter, and Moody's Analytics revenue growth, which the 10-Q reports at just 4% globally (US +7%, international +2%) with 8% organic constant currency — the recurring half is growing at mid-single digits and the market is paying a subscription multiple for it. Also watch the operating expense line: the 10-Q attributes margin expansion to '5% growth in operating and SG&A expenses' against 15% revenue growth, and that gap closes when issuance slows. And watch for any restatement or further detail on the MA Regulatory Solutions divestiture, which is absent from every vendor field and which inflated the reported EPS. Note that the vendor payload contains NO earnings calendar for Moody's, so the date itself is inferred from filing cadence rather than published."
Confidence
Low

Medium term 6-24 months

Neutral
Driver
"The medium term is a debt-issuance cycle wrapped around a franchise that does not change. When issuance is open, this business produces what the June quarter produced: revenue +15.1%, operating expenses +5%, operating income +24.1%. When it closes, it produces FY2022: revenue down 12.1% and net income down 38%. Consensus assumes the former, with revenue growth of 7.4% in each of FY2026 and FY2027 and EPS growth of 14.9% then 11.7%. The supports are genuine: a 45.1% operating margin, 23.9% return on invested capital, roughly $3.2 billion of trailing free cash flow, `netDebtToEBITDATTM` of 1.51x, and a buyback that consumed $1,706 million in FY2025 — 2.0% of the market capitalisation — plus $701 million of dividends at a $3.94 trailing rate. Combined shareholder yield is approximately 2.9%. The knowledge base's expectation, from business_breakdowns at conviction 70, is that Moody's 'should grow GDP-plus, raise prices 3-4%/yr, and smooth cyclicality as Analytics lifts recurring revenue to 68%' — a reasonable base case that the current 4% Analytics growth rate does not yet corroborate."
What we’re watching
"Whether Moody's Analytics reaccelerates. At 4% reported growth it is diluting rather than smoothing the cyclicality the knowledge base expects it to smooth, and the divestiture of MA Regulatory Solutions narrows it further. Whether debt issuance holds: this is the single external variable, it is rate- and spread-dependent, and the FY2022 experience is the template for what happens when it stops. Whether the operating margin can hold above 45% — it expanded on a 15%-versus-5% revenue-to-cost gap that will not persist. Whether the buyback continues near $1.7 billion; treasury stock stands at $14,978 million and has grown roughly $1.6 billion a year. Whether regulatory or litigation exposure re-emerges; the knowledge base's 2021 claim that the agencies are 'now insulated from underwriting litigation and helped by regulation' is five years old and is a claim about a legal environment, not about economics. And whether the company discloses the AI-related economics of the analytics business, which the 10-K describes as powering 'AI-enabled cloud-based workflow tools' without quantifying anything."
Confidence
Low

Long term 2+ years

Tailwind
Driver
"Over a decade this is one of a small number of businesses whose competitive position is close to structural, and the knowledge base states the case better than we can. A credit rating from one of two recognised agencies lowers a borrower's cost of capital by more than the rating costs, so the standard is self-enforcing: as business_breakdowns puts it, 'using an alternative costs ~0-50bps more interest, so the standard is entrenched'. Regulatory recognition of the agencies reinforces rather than erodes it. The result is a company with a 45.1% operating margin, a 23.9% return on invested capital, roughly 16,000 employees across more than 40 countries producing $7.7 billion of revenue, and pricing power the same source estimates at 3-4% a year. The volume driver is the stock of global debt, which grows with nominal GDP and with financialisation, and Moody's takes a toll on each new issue. Layered on top is a data business built on a century of proprietary credit history, now being pointed at machine learning. The long-run stance is tailwind for the franchise without reservation. This dive's disagreement is entirely with the price."
What we’re watching
"Whether the duopoly survives a technological challenge — the most plausible long-run threat is not a third agency but a machine-learning credit model that investors trust without a rating, and the knowledge base's own framing (a 'protocol network effect') implies the standard is social rather than technical, which cuts both ways. Whether disintermediation of public debt markets by private credit reduces the number of rated issues; a loan that never becomes a bond is never rated. Whether Analytics becomes half the company and whether it earns ratings-like margins. Whether the equity structure remains sustainable: $4,054 million of book equity against $8,234 million of goodwill and intangibles is a negative tangible position maintained deliberately by buyback. Whether regulation turns hostile again. And chief-executive continuity: Robert Scott Fauber has led the company since 2021, and the file contains no succession disclosure."
Confidence
Medium

Exponential Potential

Exponential Potential4/10Moderate

"Rated 4 — an exceptional moat attached to a linear revenue base, with one genuine option. What Moody's owns is a standard: the knowledge base's business_breakdowns claim describes it precisely — 'Like Moody's/S&P in ratings, FICO is the accepted securitization standard — using an alternative costs ~0-50bps more interest, so the standard is entrenched.' A rating that lowers a borrower's cost of capital by tens of basis points is worth far more than it costs, which is why pricing power of 3-4% a year is durable and why the same speaker puts terminal-value certainty high enough to call it 'ownable for 30+ years'. That is a superb business and it is not an exponential one: ratings revenue scales with the number and size of debt issues, which grows with nominal GDP. The option is Moody's Analytics, at $4,840 million of FY2025 revenue on the vendor's labelling — a data, research and risk-software business the 10-K describes as powering 'AI-enabled cloud-based workflow tools'. If the proprietary credit dataset built over a century becomes a machine-learning asset rather than a publishing asset, the economics change. The evidence so far is unimpressive: MA revenue grew 4% in the June quarter, 8% organic constant currency, and the company divested MA Regulatory Solutions in the same quarter — a narrowing, not a scaling. A 4, not higher, because the moat is real and the growth curve is not accelerating."

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 18%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $515, earnings would have to compound roughly 18% a year for 10 years (9% discount rate). Analysts forecast ~14%/yr, so the market is pricing in MORE than what the Street expects.

> ## DATA BANNER — PROSE-ONLY FILINGS

> The SEC extraction for Moody's contains ZERO [TABLE] markers in the 10-K (425,128 characters) or the 10-Q (209,792 characters) — "tables": false in the manifest, confirmed by direct inspection.

> No financial statement survived extraction, and searches for the company's own "Capital additions" line return no hits. The 8-K earnings-release exhibits are also absent.

> Consequence: the capital-expenditure check could not be performed and no figure in the financial tables below is filing-verified. The narrative disclosures quoted — including the divestiture attribution and the segment growth rates — ARE filing-sourced.

> Additionally, the vendor payload contains NO earn_cal entries for this name at all — no past actual-versus-estimate record and no forward date.

Reference table

Street consensus$545.15 (+12.7%) · median $535 · high $610 · low $500 — 3.4% ABOVE spot · 0 strong buy / 18 buy / 13 hold / 1 sell across 32 analysts
Valuation28.6x FY2026E · 25.6x FY2027E · 22.9x FY2028E · 30.7x trailing GAAP diluted · 22.5x EV/EBITDA · 28.1x book — an artefact, see Section 5
June quarter (vendor-sourced; narrative filing-verified)Revenue $2,185M (+15.1%) · operating income $1,046M (+24.1%) · diluted EPS $5.02 against $3.20 (+56.9%) — and the 10-Q attributes the EPS increase to "growth in operating income coupled with the gain on the divestiture of the MA Regulatory Solutions business"
The item inside itThe residual between operating income and pre-tax income swung from MINUS $24M (Q2 2025) to PLUS $192M (Q2 2026) — a $216M favourable swing the filing attributes principally to the divestiture. On operating income alone the quarter grew 24.1%, and that is the number used here
Margins — trailingOperating 45.1% · EBITDA 49.0% · net 34.3% · return on invested capital 23.9% · netDebtToEBITDATTM 1.51x
Capital return$1,706M repurchased in FY2025 — 2.0% of market capitalisation — plus $701M of dividends at a $3.94 trailing rate, 0.81% yield · combined shareholder yield approximately 2.9%
Conviction5 claims, ALL BULLISH, convictions 70-85 — and effectively TWO voices, with the most recent dated February 2024. Every claim is about durability, none about price
Technicals−10.37% from the 52-week high of $539.61; +17.33% above the low of $412.23; +3.0% above the 50-DMA ($469.48) and +2.5% above the 200-DMA ($471.80); RSI 38.4; MACD +2.77; 12-month −3.51% vs SPY +24.26% — a twenty-eight-point deficit

What the experts actually said 4 traceable claims on MCO · showing the highest-conviction voices

“Moody's has an unassailable protocol-network-effect moat; extremely unlikely to lose its ~40% share; high terminal-value certainty makes it ownable for 30+ years.”
Business Breakdownsbullishconviction 822024-02-23business_breakdowns-szwZTdDrr3w:40a9a29b6e
“Moody's and S&P Global are a natural duopoly rating 90% of world debt; longest-held names, still love them, and think they have a lot more to go.”
We Study Billionairesbullishconviction 802021-10-22we_study_billionaires-csn-II3Xg9c:d2700bdcbe

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

402439476513550Aug '25Nov '25Jan '26Apr '26Jun '26Aug '2652w hi $540Price 51550-DMA 484200-DMA 47352w lo $412

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Data summary: last close $514.95, 6% above the 50-day average ($484), 9% above the 200-day average ($473) — an uptrend. 5% below the 52-week high of $540, 25% above the 52-week low of $412.

Bollinger Bands 20-day average ± 2 standard deviations

372427482537592Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26Price 51520-day avg 492

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

Data summary: price $514.95 is currently inside the band (band $463–$520).

RSI (14) momentum gauge · 0–100

705030Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26RSI 65.7

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 66.

MACD 12 / 26 / 9 · trend & momentum

0Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26MACD 8.6signal 5.8

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Data summary: MACD is currently above its signal line by 2.77, positive momentum.

Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago

7889100112123Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26S&P 500 119XLF (sector) 108MCO 101

Solid = MCO · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

036912$6BFY23EPS $10$7BFY24EPS $12$8BFY25EPS $15$8BFY26EEPS $17$9BFY27EEPS $19$10BFY28EEPS $21$10BFY29EEPS $23$11BFY30EEPS $25

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$514.95
Market cap$89B
P/E trailing32×
P/E FY26E / FY27E30× / 27×
EV / Sales11.5×*
EV / EBITDA23.5×*
Gross margin71.9%
Net margin34.3%
Dividend yield0.78%
Beta1.33
52-wk range$412 – $540
RSI(14)75
50 / 200-DMA$484 / $473
12-mo return+1% (SPY +19%)
Street target$541 ($500–$597)
Analyst grades18 Buy · 13 Hold · 1 Sell
FMP ratingB
Next earnings'Third-quarter 2026 results, expected late October 2026 on the company''s recent cadence, approximately 85 days away — the vendor payload contains NO earnings calendar for this name at all, which is itself recorded as a data gap. Second-quarter results were released 2026-07-22, thirteen days before this dive, with the 10-Q filed 2026-07-23; reported diluted EPS of $5.02 against $3.20 includes a gain on the divestiture of the MA Regulatory Solutions business.'

* Enterprise value recomputed in-house: the data vendor nets cash but omits short-term investments, overstating EV for cash-rich balance sheets. EV multiples marked * use market cap + total debt − cash − short-term investments.

1. What the business is, and the divestiture inside the quarter

Two reportable segments, per the 10-K: Moody's Investors Service (MIS) — credit ratings across approximately 140 countries — and Moody's Analytics (MA), which the 10-K describes as comprising "i) a premier fixed income and economic research business (Research & Insights); ii) a data business powered by the world's largest..." portfolio of credit information, plus decision and risk software. Chief executive Robert Scott Fauber; approximately 16,000 employees across more than 40 countries.

The June 2026 quarter (vendor-sourced; the narrative is filing-verified):

Q2 2026Q2 2025changeH1 2026H1 2025change
Revenue$2,185M$1,898M+15.1%$4,264M$3,822M+11.6%
Gross profit$1,667M$1,284M+29.8%$3,215M$2,606M+23.4%
Operating income$1,046M$843M+24.1%$1,968M$1,725M+14.1%
Operating margin47.9%44.4%+346 bps46.2%45.1%+102 bps
Interest expense$67M$47M+42.6%$133M$101M+31.7%
Pre-tax income$1,171M$772M+51.7%$2,041M$1,576M+29.5%
Residual (pre-tax − operating + interest)+$192M−$24M+$216M+$206M−$48M+$254M
Net income$878M$578M+51.9%$1,539M$1,203M+27.9%
Diluted EPS$5.02$3.20+56.9%$8.75$6.66+31.4%
Diluted shares175.9M180.5M−2.5%176.6M180.6M−2.2%

The 10-Q's own management discussion settles what happened, and this dive quotes it because the vendor payload contains no trace of the transaction:

> "Operating margin and Adjusted Operating Margin expansion reflects the 15% increase in revenue, partially offset by growth of 5% in operating and SG&A expenses... Primarily reflects the gain on divestiture of the MA Regulatory Solutions business... The increase in Diluted EPS reflects growth in operating income coupled with the gain on the divestiture of the MA Regulatory Solutions business."

Three readings.

First, the operating quarter is genuinely excellent and needs no adjustment. Revenue +15.1% against operating and SG&A expenses +5% produced operating income +24.1% and 346 basis points of margin expansion. That five-versus-fifteen gap is what this franchise looks like when debt issuance is open, and it is the number to underwrite.

Second, the headline EPS is not. The residual between operating income and pre-tax income — non-operating items net of interest — swung from MINUS $24 million a year ago to PLUS $192 million, a $216 million favourable swing, which the filing attributes principally to the divestiture gain. Against $1,171 million of pre-tax income that is 18.4%. A reader who takes $5.02 against $3.20 at face value is reading a 56.9% increase where the operating business delivered 24.1%. The vendor's inc_q reports the $5.02 without any indication of what is inside it.

Third, the divestiture narrows the segment the bulls are relying on. MA Regulatory Solutions was part of Moody's Analytics — the recurring, subscription half of the company. The knowledge base's expectation, from business_breakdowns at conviction 70, is that Analytics will "smooth cyclicality" by lifting "recurring revenue to 68%". Selling part of it moves in the other direction.

The segment growth detail, from the same 10-Q: "The 4% increase in global MA revenue reflects growth both in the U.S. (7%) and internationally (2%). Organic constant currency revenue growth was 8%." Moody's Analytics grew 4% reported and 8% organic constant currency in a quarter when the consolidated top line grew 15.1%. The ratings half carried the quarter.

The other corporate action in the record is small and worth noting: the 10-K discloses that Moody's has "enhanced our footprint in domestic markets by expanding in Latin American markets through Moody's Local domestic rating business, including the acquisition of ICR Chile." FY2025 acquisitionsNet of −$187 million is consistent with that scale.

The 8-K record is otherwise routine: an Item 5.07 annual-meeting report (2026-04-16 — ten directors elected, KPMG ratified, say-on-pay approved) and two Item 2.02 earnings releases (2026-04-22 and 2026-07-22), neither of whose Exhibit 99.1 survives in the extraction. No spin-off, no segment realignment, no split and no notes offering.

2. The annual series, and the year that shows the risk

FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$5,371M$6,218M$5,468M$5,916M$7,088M$7,718M
Growth—+15.8%−12.1%+8.2%+19.8%+8.9%
Operating income$2,447M$2,844M$1,997M$2,221M$2,971M$3,455M
Operating margin45.6%45.7%36.5%37.5%41.9%44.8%
Net income$1,778M$2,214M$1,374M$1,607M$2,058M$2,459M
Change—+24.5%−37.9%+17.0%+28.1%+19.5%
Diluted EPS$9.39$11.78$7.44$8.73$11.26$13.67
Diluted shares189.3M187.9M184.7M184.0M182.7M179.9M
Share repurchase——$1,070M$561M$1,383M$1,706M

FY2022 is the most important row in this file and it is the reason the risk score is 4 rather than 2. Revenue fell 12.1%, the operating margin fell 920 basis points to 36.5%, and net income fell 37.9% — with the moat entirely intact. Global debt issuance froze as rates rose, and a business that takes a toll on each new issue collected fewer tolls. The recovery has been complete and then some — FY2025 revenue is 41.1% above FY2022 — but a reader paying 25.6x forward earnings should know that this specific company has produced a 38% earnings decline within the last four years, without anything going wrong with the franchise.

The share count has fallen 5.0% since FY2020, and the buyback has accelerated: $1,706 million in FY2025, up 23.4% on FY2024, 2.0% of the current market capitalisation.

3. Cash flow and the balance sheet

The capital-expenditure check: COULD NOT BE PERFORMED — and the field looks wrong

The manifest records "tables": false for all six Moody's filings, and direct inspection confirms zero [TABLE] markers in the 10-K (425,128 characters) and zero in the 10-Q (209,792 characters). Searches for the company's own "Capital additions" line return no hits. The check is unavailable.

And the field looks wrong on its own internal arithmetic:

FY2022FY2023FY2024FY2025Trailing (derived)
Operating cash flow$1,474M$2,151M$2,838M$2,901M~$3,481M
Capital expenditure$283M$271M$317M$326M~$83M
Free cash flow$1,191M$1,880M$2,521M$2,575M~$3,398M
Capex ÷ D&A0.855x0.727x0.735x0.679x0.160x
FCF yield———3.07%4.06%

Trailing figures derived from freeCashFlowYieldTTM (4.0563%) and capexToOperatingCashFlowTTM (0.0238) against the $83.772B market capitalisation.

The trailing capital-expenditure figure of approximately $83 million is 74.5% below FY2025's filed-basis $326 million, and capexToDepreciationTTM reads 0.1596 — marginally above the documented "capex below 15% of D&A" corruption threshold, and against a four-year band of 0.679x to 0.855x. A capital-intensity ratio that falls from 0.679x to 0.160x in one year is exactly the "swings more than 3x" signature that flags 919 files in the programme's census.

Stated honestly: we do not know whether this is a real reduction in capital spending or a broken field, because the filing extraction contains no cash-flow statement to check it against. What we can say is the consequence. If capital expenditure is in fact running near the FY2025 rate of $326 million, trailing free cash flow is approximately $3,155 million rather than $3,398 million, and the free-cash-flow yield is 3.77% rather than the vendor's 4.06% — a 7.2% overstatement, in the direction the programme's census says this error always runs. This dive quotes the corrected figure of approximately 3.8% and flags the field.

The balance sheet

2023-12-312024-12-312025-12-31
Cash and short-term investments$2,193M$2,974M$2,448M
Goodwill$5,956M$5,994M$6,368M
Intangible assets$2,049M$1,890M$1,866M
Total assets$14,622M$15,505M$15,830M
Short-term debt$108M$697M$0M
Long-term debt$7,001M$6,731M$6,994M
Total debt$7,415M$7,746M$7,351M
Net debt$5,285M$5,338M$4,967M
Total shareholders' equity$3,318M$3,565M$4,054M
Noncontrolling interests$158M$162M$151M
Treasury stock, at cost($12,005M)($13,322M)($14,978M)

Leverage is modest and the maturity profile is comfortable: netDebtToEBITDATTM of 1.51x, with NO short-term debt outstanding at 31 December 2025 and the 10-Q disclosing euro-denominated notes due 2027 and 2030 designated as net investment hedges.

The equity ratios are artefacts and are rejected. Shareholders' equity of $4,054 million against $8,234 million of goodwill and intangibles and $14,978 million of treasury stock produces priceToBookRatioTTM of 28.06x and returnOnEquityTTM of 79.7%. Neither is a statement about the business — this is the same buyback-driven distortion documented on Sherwin-Williams and Illinois Tool Works in this batch and on HCA in a more extreme form. The measures this dive uses instead are return on invested capital (23.9%), the operating margin (45.1%) and net debt to EBITDA (1.51x).

Enterprise value is broadly reliable. enterpriseValueTTM of $89,827M against a market capitalisation of $83,772M implies $6,055M of net claims, against FY2025 net debt of $4,967M plus noncontrolling interests of $151M — a $937 million residual consistent with first-half 2026 movements. Noncontrolling interests appear to be OMITTED, at $151 million, or 0.17% of enterprise value — the KKR / MPC / FCX class in a form small enough not to matter, and recorded as checked rather than as clean.

4. Geography and segments — the worst seg_geo in this batch after Williams

seg_geo reports a United States revenue line of $472 million. Moody's United States revenue is approximately $4,171 million.

The FY2025 block:

Vendor lineValue
"U S"$472M
EMEA$2,376M
Asia Pacific$699M
"International Regions"$3,547M
Sum as published$7,094M
inc_a revenue$7,718M
Ratio91.9%

The mechanism is identifiable. "International Regions" of $3,547M is an aggregate. Its named components in the block — EMEA $2,376M and Asia Pacific $699M — sum to $3,075M, leaving a $472M residual which is exactly the figure the block labels "U S". That $472 million is almost certainly the Americas-excluding-United-States component of the international aggregate, and it has been mislabelled as the United States.

On that reading the correct picture is:

RegionFY2025share of revenue
United States (revenue less International Regions)$4,171M54.0%
EMEA$2,376M30.8%
Asia Pacific$699M9.1%
Americas excluding US$472M6.1%
Total$7,718M100%

Two defect classes at once. The home-market line is present in name and wrong by a factor of 8.8 — a worse form of the NEM / WM / MAR omission, because a reader gets a plausible-looking number rather than an obvious gap. And an aggregate is carried alongside its own components, the CDNS / CSX / ITW over-count class, which is why the block sums to 91.9% rather than either 100% or 154%.

Corroboration that 54% is roughly right: the FY2017 block, before the labelling broke, reports "U S $2,348.4M" against "International Regions $1,855.7M" — 55.9% domestic — and the mix has drifted internationally since. All geographic figures in this dive use the rebuilt split and say so.

seg_prod ties but its labels cannot be trusted either. FY2025 reports "Moodys Analytics $4,840M" and "Moodys Investors Service $2,878M", summing to $7,718M — exactly revenue. But the labelling flips across years in a way that cannot all be correct: FY2019 shows Analytics $1,954M against MIS $2,875M; FY2020 shows Analytics $3,292M against MIS $2,079M; FY2021 shows Analytics $3,812M against MIS $2,406M. A segment cannot grow from $1,954M to $3,292M and then have the smaller partner grow from $2,875M to $2,079M. At least some rows are transposed, and the prose-only extraction contains no segment revenue table to resolve which. This dive therefore uses the segment SUM (which ties) and the segment GROWTH RATES the 10-Q states in prose (MA +4% reported, +8% organic constant currency), and quotes no segment revenue level as fact.

5. Valuation — priced in or room?

At $483.67 (market cap $83.772B):

TrailingFY2026EFY2027EFY2028E
Consensus adjusted EPS—$16.921 (16)$18.895 (16)$21.112 (8)
Growth—+14.9%+11.7%+11.7%
P/E30.7x (GAAP diluted)28.6x25.6x22.9x
Revenue (consensus)$7,718M (FY2025)$8,279.6M (17)$8,890.2M (17)$9,564.3M (14)
Revenue growth+8.9%+7.3%+7.4%+7.6%
PEG on FY2027——~2.2—
EV / EBITDA22.5x———
Free cash flow yield (corrected)~3.8%———
Dividend yield0.81%———
Operating margin45.1%———
Return on invested capital23.9%———
Net debt / EBITDA1.51x———
Price / book28.1x — ARTEFACT———

Estimate coverage is good on the near years. 16 analysts on both FY2026 and FY2027 EPS — the FY2027 range of $17.995 to $19.351 is a 7.5% spread, the narrowest in this batch and consistent with a highly predictable franchise — and 8 on FY2028. FY2029 and FY2030 rest on 6 analysts each and are excluded from every conclusion.

est.epsAvg is verified. FY2025's $14.721 against a reported GAAP diluted $13.67 is a 7.7% gap, consistent with the company's adjusted basis excluding acquisition amortisation and one-off items. The FY2024 estimate of $12.429 against a reported $11.26 shows the same 10.4% wedge, so the basis is consistent and the field is sound. Every forward multiple here is an adjusted multiple and the trailing 30.7x is shown separately.

est.ebitdaAvg and est.ebitAvg are REJECTED with the signature stated. In every year from FY2023 to FY2030, ebitdaAvg is exactly 47.01% of revenueAvg and ebitAvg is exactly 41.26%. Moody's actual FY2025 EBITDA margin was 51.0% on the vendor's own income statement and the trailing figure is 49.0%. The fabricated ratio is applied mechanically across eight years and, unusually for this defect, is BELOW the actual rather than above it. All forward valuation uses epsAvg.

5a. What today's price assumes (the inversion)

At $483.67 — 28.6x FY2026 consensus and 25.6x FY2027 — the price embeds:

5b. The return bridge (why the multiple moves)

Expected return over the next twelve months decomposes as: adjusted EPS growth (+11.7%, FY2026E $16.921 to FY2027E $18.895) + multiple drift (roughly HELD, from 28.6x on today's forward year to about 27.5x on the then-forward year) + shareholder yield (+2.9%, being 0.81% dividend and roughly 2.0% buyback) ≈ +13%.

Our base assumes the multiple holds rather than compresses, which is more generous than the treatment given to Sherwin-Williams or Illinois Tool Works in this batch, and the reason is the franchise quality. A business with a 45.1% operating margin, a 23.9% return on invested capital and a genuine duopoly position deserves a premium multiple through a cycle, and 25.6x forward is within the range Moody's has occupied for a decade.

What it does not deserve is a premium multiple AND a full price at the same time, which is what $483.67 is. Base fair value of $491 is 1.6% above spot precisely because we are willing to underwrite the multiple and unwilling to underwrite anything beyond it.

At 20x FY2027E the price is $378 (−21.9%). At 30x it is $567 (+17.2%).

5c. Variant perception (where we differ, what would surprise)

Synthos fair values

All three anchors are multiples of the FY2027 consensus adjusted EPS distribution (mean $18.895, low $17.995, high $19.351; 16 analysts), cross-checked against the corrected free-cash-flow yield. Price-to-book is unavailable as a cross-check because the ratio is a buyback artefact.

Base is 1.6% above spot; asymmetry roughly 1.09:1 (25.6% down, 28.0% up), before a shareholder yield of approximately 2.9%. A base at spot and a payoff ratio at parity is a Hold, on one of the best businesses in this batch, and both halves of that sentence are meant.

6. Knowledge base — five claims, all bullish, two voices, and none about price

Raw hits: 5. After a case-sensitive entity re-run: 5. Name-level claims on Moody's: 5, ALL BULLISH. Discarded: 0.

The case-sensitive entity sweep ran MCO, Moody's and Moodys across all 52,021 distilled claims and returned five hits with no homograph contamination — a good result for a three-letter ticker, and better than CEG, PWR, EMR, USB or MMM managed.

All five, verbatim:

> 2021-10-22 · BULLISH · conviction 80 · channel: we_study_billionaires · speaker: Dev Kantesaria · role: independent · entities: MCO, SPGI

> "Moody's and S&P Global are a natural duopoly rating 90% of world debt; longest-held names, still love them, and think they have a lot more to go."

> 2021-10-22 · BULLISH · conviction 80 · channel: we_study_billionaires · speaker: Dev Kantesaria · entities: MCO, SPGI

> "Moody's and S&P Global, his longest-held names, are a natural duopoly rating 90% of world debt, now insulated from underwriting litigation and helped by regulation; he thinks they have a lot more to go."

> 2023-05-29 · BULLISH · conviction 85 · channel: business_breakdowns · entities: FICO, Moody's, S&P Global

> "Like Moody's/S&P in ratings, FICO is the accepted securitization standard — using an alternative costs ~0-50bps more interest, so the standard is entrenched."

> 2024-02-23 · BULLISH · conviction 82 · channel: business_breakdowns · speaker: Brian Yakman · role: independent · entity: MCO

> "Moody's has an unassailable protocol-network-effect moat; extremely unlikely to lose its ~40% share; high terminal-value certainty makes it ownable for 30+ years."

> 2024-02-23 · BULLISH · conviction 70 · channel: business_breakdowns · speaker: Brian Yakman · entity: MCO

> "As a toll-taker on global debt issuance Moody's should grow GDP-plus, raise prices 3-4%/yr, and smooth cyclicality as Analytics lifts recurring revenue to 68%."

What this lane is, stated without inflation.

The quality is high and the content is right. The third claim contains the best available one-sentence explanation of why this business earns what it earns: a rating that costs less than the interest saving it produces is a self-enforcing standard, and "using an alternative costs ~0-50bps more interest" is the whole moat in nine words. The fourth claim's "protocol network effect" framing is a better description than "brand" or "regulation", because it explains why a technically superior competitor still fails: the value is in universal acceptance, not accuracy.

Three qualifications, all of which reduce the weight this lane can carry.

Breadth is 2, not 5. Two claims are Dev Kantesaria on a single day in October 2021 — one voice, one episode, near-identical content. Three are business_breakdowns, of which two are Brian Yakman on a single day in February 2024. Removing business_breakdowns leaves a single speaker from five years ago. The concentration test is the same discipline applied to Cummins in this batch, where two claims from one channel were graded breadth 1.

The lane is old. The most recent claim is dated 2024-02-23, two and a half years ago. In the interval the stock rose to $539.61 and fell to $412.23. Nothing in the store addresses the current price.

And every claim is about durability, not valuation. "Ownable for 30+ years", "high terminal-value certainty", "a lot more to go", "grow GDP-plus, raise prices 3-4%/yr" — these are statements about the discount rate and the terminal value, not about the entry multiple. A moat claim at conviction 82 does not become a buy signal by being repeated at a higher price, and this dive treats it as the durability input it is: it is why the risk score is 4, the lowest in this batch, and it is not why the verdict would be a Buy.

One claim has aged in a way worth noting. The 2021 assertion that the agencies are "now insulated from underwriting litigation and helped by regulation" is five years old and is a claim about a legal and political environment rather than about economics. Regulatory posture toward the rating agencies has changed before and can change again; the claim is recorded and is not treated as permanent.

Attribution note: three of the five carry a named speaker (Dev Kantesaria twice, Brian Yakman twice) with speaker_role: independent; the 2023 claim carries speaker: null. Under the standing rule that speaker_role is unreliable, the tags are noted rather than relied upon. No management voice appears.

Conclusion. Breadth 2, claim count 5, net conviction positive-moderate. The Synthos knowledge base is unanimously and articulately positive on the Moody's franchise, from two voices, and it has not said anything about it since February 2024. We accept the moat argument in full and it does not change the arithmetic in Section 5.

7. Data integrity — a prose-only file with two structural segment failures

Six findings.

0. THE FILINGS ARE PROSE-ONLY — the capex check could not be performed. "tables": false in the manifest, confirmed by direct inspection: zero [TABLE] markers in the 10-K (425,128 characters) and zero in the 10-Q (209,792 characters), with searches for the company's own "Capital additions" line returning no hits. The 8-K earnings-release exhibits are also absent from the extraction. No figure in the financial tables of this dive is filing-verified; the narrative disclosures quoted — the divestiture attribution, the 15%-versus-5% expense gap, the MA growth rates, the ICR Chile acquisition and the employee count — ARE.

1. capitalExpenditure — the trailing figure trips the corruption screen and CANNOT be checked. FY2025 reads −$326M against D&A of $480M (0.679x), consistent with FY2022-FY2024 at 0.855x, 0.727x and 0.735x. But capexToDepreciationTTM reads 0.1596 and capexToOperatingCashFlowTTM reads 0.0238, implying trailing capital expenditure of approximately $83 million — a 74.5% collapse in one year. That is both the "capex below 15% of D&A" signature (marginally) and the "capex/D&A swings more than 3x" signature. The consequence, and it runs in the direction the census predicts: freeCashFlowYieldTTM of 4.06% becomes approximately 3.77% if capital expenditure is in fact running at the FY2025 rate — a 7.2% overstatement. This dive quotes approximately 3.8% and states that the field is unverified.

2. seg_geo mislabels the home market by a factor of 8.8 AND carries an aggregate alongside its components — REJECTED, rebuilt, and used. The FY2025 block reports "U S" $472M, EMEA $2,376M, Asia Pacific $699M and "International Regions" $3,547M, summing to $7,094M against revenue of $7,718M — 91.9%. The mechanism: International Regions $3,547M less EMEA $2,376M less Asia Pacific $699M leaves exactly $472M — the figure labelled "U S", which is therefore the Americas-excluding-United-States component of the international aggregate. Actual United States revenue is revenue less International Regions = approximately $4,171M, 54.0% of the total — 8.8 TIMES the labelled figure. This is worse than the NEM / WM / MAR home-market omission class, because a reader gets a plausible-looking wrong number rather than an obvious gap, and it simultaneously commits the CDNS / CSX / ITW over-count error. Corroborated by the FY2017 block, before the labelling broke, which reports "U S $2,348.4M" against "International Regions $1,855.7M" — 55.9% domestic. The rebuilt split is used throughout.

3. seg_prod sums correctly and its LABELS are transposed in at least some years — segment LEVELS not used. FY2025 reports "Moodys Analytics $4,840M" and "Moodys Investors Service $2,878M", summing to $7,718M, exactly revenue. But the labelling flips implausibly across the history: FY2019 shows Analytics $1,954M against MIS $2,875M, while FY2020 shows Analytics $3,292M against MIS $2,079M and FY2021 Analytics $3,812M against MIS $2,406M. Analytics cannot grow from $1,954M to $3,292M in a year while the ratings business simultaneously falls from $2,875M to $2,079M in a year when total revenue ROSE from $5,371M... to restate: at least some rows are transposed and the prose-only extraction contains no segment revenue table to establish which. This dive uses the segment SUM (which ties) and the segment GROWTH RATES the 10-Q states in prose (MA +4% reported, +8% organic constant currency) and quotes no segment revenue level as fact.

4. The MA Regulatory Solutions divestiture is absent from every vendor field — and it inflates the reported June-quarter EPS. The 10-Q attributes the increase in diluted EPS to "growth in operating income coupled with the gain on the divestiture of the MA Regulatory Solutions business", and the residual between operating income and pre-tax income swung from minus $24M to plus $192M — a $216M favourable swing, 18.4% of pre-tax income. inc_q reports diluted EPS of $5.02 with no indication of what is inside it. This is the "whole transaction absent" defect class.

5. est.ebitdaAvg and est.ebitAvg carry a fixed-ratio fabrication signature — REJECTED. In every year from FY2023 to FY2030, ebitdaAvg is exactly 47.01% of revenueAvg and ebitAvg is exactly 41.26%. Moody's actual FY2025 EBITDA margin was 51.0% and the trailing figure is 49.0%. Unusually for this defect the fabricated ratio is BELOW the actual rather than above it, but it is still a fixed ratio applied mechanically across eight years. All forward valuation uses epsAvg, whose adjusted-basis wedge against GAAP is consistent at 7.7% (FY2025) and 10.4% (FY2024).

6. priceToBookRatioTTM and returnOnEquityTTM are artefacts — NOT USED. Book value per share of $17.24 against a $483.67 price gives 28.06x; return on equity reads 79.7%. Both follow from $14,978 million of treasury stock reducing book equity to $4,054 million against $8,234 million of goodwill and intangibles. The same buyback distortion documented on Sherwin-Williams and Illinois Tool Works in this batch, and on HCA in the extreme negative-equity form. The measures used here are return on invested capital (23.9%), the operating margin (45.1%) and net debt to EBITDA (1.51x).

Two further gaps worth recording. The earn_cal block is COMPLETELY ABSENT for this name — no historical actual-versus-estimate record and no forward date, so the "next catalyst" in this dive is inferred from filing cadence rather than published, and no beat-and-miss pattern could be assessed. And the peers block contains exactly ONE entry: Brookfield Asset Management. For the world's second-largest credit rating agency, a peer set consisting of a single alternative-asset manager is the thinnest in this batch by a wide margin — S&P Global, FICO, MSCI, ICE, Morningstar and Fitch's parent are all absent. No peer-multiple comparison is drawn.

Enterprise value — checked, and effectively clean. enterpriseValueTTM of $89,827M implies $6,055M of net claims against FY2025 net debt of $4,967M plus noncontrolling interests of $151M, a $937M residual consistent with first-half movements. The $151M of noncontrolling interests appears omitted, at 0.17% of enterprise value — the KKR / MPC / FCX class in a form small enough to be immaterial.

Non-equity tripwire — checked and passed. MCO is common stock, NYSE-listed. Price of $483.67 is not par-like; beta is 1.335; the dividend is a declared and rising quarterly rate ($3.94 trailing, 0.81% yield); volume was 502K shares (~$243M of turnover); the 52-week band of $412.23 to $539.61 is a 31% range. No preferred stock is outstanding; noncontrolling interests are $151 million. This is common equity.

Vendor composite rating — noted, half-discredited. B / 3 overall, with 5 on return on equity, 5 on return on assets, and 1 on each of debt-to-equity, price-to-earnings and price-to-book. The return-on-equity score of 5 and the price-to-book score of 1 are both computed on the treasury-stock-distorted equity base rejected in finding 6. Not used.

8. Technicals

Today's move

MCO closed 2026-08-04 at $483.67, up 0.06% or $0.31 from $483.36, on 502,000 shares — a 1.5% intraday range on the lightest volume in this batch. No company-specific filing is dated 2026-08-04; the last events were the 2026-07-22 earnings release and the 2026-07-23 10-Q, thirteen days earlier.

The honest read: nothing happened, and nothing has been happening for a year. A flat day on light volume, above both moving averages by less than 3%, at 25.6x forward earnings, twenty-eight points behind the index over twelve months. This is a quality compounder in a period of neither enthusiasm nor distress, and the entry is neither a discount nor a chase. That is the definition of Hold — and the $415 buy trigger in Section 10 exists because a business of this quality is worth having a price for.

9. Insiders

The insider block for Moody's returned no usable transactions in this payload. There is nothing to report and nothing is invented to fill the section. Where other names in this batch produced director awards, gift transfers or programmed sales, this file is silent, and a silent insider file is uninformative in both directions.

10. Verdict, kill-criteria and flip conditions

Hold.

The business first, because it deserves it. Moody's is one of two firms whose credit opinions the world's debt markets treat as a standard, and the knowledge base's description of the mechanism is exact: "using an alternative costs ~0-50bps more interest, so the standard is entrenched." The financial evidence is a 45.1% trailing operating margin, a 49.0% EBITDA margin, a 23.9% return on invested capital, roughly $3.2 billion of trailing free cash flow on $7.7 billion of revenue, 1.51x net leverage with no short-term debt outstanding at the last year end, and a June quarter in which revenue grew 15.1% while operating and SG&A expenses grew 5%. Five independent expert claims in the store, every one bullish, at convictions of 70 to 85, one of which calls it "ownable for 30+ years". We agree with all of that and the risk score of 4 is the lowest in this batch because of it.

Why it is a Hold and not a Buy, in three items.

First, the arithmetic. At $483.67 the shares are 28.6x FY2026 consensus and 25.6x FY2027's $18.90 for 11.7% forecast EPS growth — a PEG near 2.2. Base fair value $491, 1.6% above spot; bear $360; bull $619; asymmetry 1.09:1.

Second, the most recent quarter is not what the headline says. Diluted EPS of $5.02 against $3.20 is +56.9%. Operating income grew 24.1%. The 10-Q attributes the difference to "the gain on the divestiture of the MA Regulatory Solutions business", and the residual between operating and pre-tax income swung $216 million favourably. The vendor payload contains no trace of the transaction.

Third, the thing that is supposed to de-risk the franchise is not doing so. Moody's Analytics grew 4% reported (8% organic constant currency) while the group grew 15.1%, and the company has just divested part of it. The knowledge base's own base case is that Analytics "smooths cyclicality" by lifting recurring revenue to 68%. At 4% growth it is diluting rather than smoothing, which means the earnings remain levered to debt issuance — and FY2022 shows what that means: revenue −12.1%, net income −37.9%, with the moat intact.

And the honest counterweight. The knowledge base's moat argument is correct, and a business with genuine terminal-value certainty deserves to be owned rather than traded. A reader who already holds this should hold it: the franchise is not impaired, the buyback is retiring 2% of the shares a year, and paying 25.6x for a duopoly is not a mistake — it is simply not an opportunity. A reader who does not hold it is being asked to accept a 1.09:1 payoff for the privilege.

Pre-registered BUY trigger — what would make this Buy — Tactical:

Pre-registered KILL criteria — what would take this to Avoid:

Where MCO fits in the Synthos Framework Portfolio. No position today. Tracked on the financials / data watch list at the $415 buy trigger above, with a 2.5% initial size and a 5% target if triggered — larger than most triggers in this batch, because the risk score of 4 is the lowest here and because a duopoly with 23.9% returns on invested capital is a name to hold in size when the price permits. Sizing note: the correct discipline on a genuinely superb business is a standing limit order at a price that a cyclical revenue interruption will eventually produce, not a decision about whether the business is good. Logged as a tracked Synthos call (Hold) as of 2026-08-04 at $483.67, with the fair-value anchors, the buy trigger, the kill criteria and the 5a assumptions all gradeable. Also logged as a DATA flag: this name's filing archive is prose-only, its seg_geo United States line is wrong by a factor of 8.8, its seg_prod labels are transposed in at least some years, its earn_cal block is empty and its peer set contains one name. The capital-expenditure check remains outstanding.

Single biggest risk: debt issuance stopping. Moody's Investors Service takes a fee on each new debt issue, and the volume of new debt issues is set by interest rates, credit spreads and corporate appetite — none of which the company influences. In FY2022, when issuance froze, revenue fell 12.1% from $6,218 million to $5,468 million, the operating margin fell 920 basis points to 36.5%, and net income fell 37.9%. The moat was fully intact throughout. That is the specific shape of this downside: not competitive loss, not disruption, not regulation — simply fewer bonds. Moody's Analytics was supposed to buffer it, and at 4% growth after a divestiture it is not yet doing so. At 25.6x FY2027 consensus with a 1.09:1 payoff and a base fair value at spot, an investor is being asked to pay a full price for a franchise whose earnings have fallen 38% in a single year within the last four. The right response is a written price, and it is $415.

Provenance & disclosures